Skip to content

News

Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)

Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)

We need your help to strengthen critical gynecologic cancer education and awareness programs. (October 16, 2019) Recently, Rep. Rosa DeLauro (D-CT)—leader of the Congressional Ovarian Cancer Caucus and an ovarian cancer survivor herself—introduced HR 4560, legislation to reauthorize Johanna’s Law, also known as The Gynecologic Cancer Education and Awareness Act. Johanna’s Law supports a variety … Continued

OCRA-Funded Research Elucidates New Immunotherapy Approach

OCRA-Funded Research Elucidates New Immunotherapy Approach

(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach. In order to enable ovarian cancer patients to benefit from immunotherapy, Dr. Michael Goldberg’s research sought to understand how standard-of-care chemotherapy influences immune cells around the … Continued

Ovarian Cancer Quiz: Test Your Ovarian Cancer Knowledge

Ovarian Cancer Quiz: Test Your Ovarian Cancer Knowledge

It’s important for everyone to know the symptoms and risk factors for ovarian cancer. If you or someone you know are experiencing any of the symptoms listed below, take notice and take it seriously—and also know that their presence does not automatically indicate ovarian cancer. Take our ovarian cancer quiz: Want to deepen your understanding … Continued

OCRA-Funded Research Points to Surrounding Tissues for Further Study

OCRA-Funded Research Points to Surrounding Tissues for Further Study

(September 10, 2019) Ovarian clear-cell carcinoma is an aggressive form of ovarian cancer.  Endometriosis is derived from the uterine endometrium and is a known risk factor for ovarian clear-cell carcinoma.  Evidence supports ovarian clear-cell origins in the uterine endometrium.   It has been known for years that co-occurring cellular mutations are observed in ovarian clear-cell carcinoma, … Continued

OCRA-Funded Research Moves Immunotherapy Forward

OCRA-Funded Research Moves Immunotherapy Forward

(September 5, 2019) OCRA funded investigator Dmitriy Zamarin, MD, PhD contributed to a study that provides an intriguing hypothesis that mutation in genes like SMARCA4 may improve tumor recognition by the immune system. The body’s immune system plays a major role in controlling tumor growth. Specialized immune cells called T-cells identify cancer cells as “foreign” … Continued

September is Ovarian Cancer Awareness Month

September is Ovarian Cancer Awareness Month

Every September, we come together to shine a spotlight on ovarian cancer, spread awareness, and raise critical funds for research and patient support. How you can help during Ovarian Cancer Awareness Month: Give to ovarian cancer research and support Your support has a direct impact in funding new research and programs that support survivors and … Continued

BE LOUD Video Series Turns Up the Volume on Ovarian Cancer

BE LOUD Video Series Turns Up the Volume on Ovarian Cancer

(August 21, 2019) Every 23 minutes, another woman in the U.S. hears the words “You have ovarian cancer” for the first time. Because ovarian cancer symptoms can be subtle and attributed to other factors, diagnosis often comes as a surprise. And along with it comes a host of overwhelming information, decisions to be made, and … Continued

OCRA Funded Research Reveals New Drug Therapy Combination

OCRA Funded Research Reveals New Drug Therapy Combination

(July 26, 2019) OCRA grantee Michael Yaffe, MD, PhD, led a study published earlier this month in Cell Systems which found success targeting cancer cells by combining two existing classes of drugs. Dr. Yaffe and colleagues found that this combination, which targets the cancer cells’ ability to divide, dramatically increases the drug’s capacity to kill … Continued

Watch OCRA’s 2019 National Conference Presentations on Live Stream

Watch OCRA’s 2019 National Conference Presentations on Live Stream

Couldn’t make it to our National Conference? Watch our expert presentations LIVE! For the first time, we live streamed all general sessions, so you can watch as our expert speakers present the latest ovarian cancer updates, from wherever you are. These broadcasts will remain available for viewing for a limited period of time following the original … Continued

An Interview With President & CEO Audra Moran

An Interview With President & CEO Audra Moran

(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to go through it alone. OCRA’s Woman to Woman program matches gynecologic cancer patients with trained survivor volunteers to provide support and mentoring to women when … Continued

OCRA and American Cancer Society Launch New Ovarian Cancer Research Collaboration

OCRA and American Cancer Society Launch New Ovarian Cancer Research Collaboration

Four multidisciplinary teams to be funded to study survivorship (June 13, 2019) In a new collaboration, the American Cancer Society and Ovarian Cancer Research Alliance have joined forces to fund multidisciplinary research projects to explore new ways of detecting, treating, and preventing ovarian cancer relapse and for improving quality of life among those diagnosed with … Continued

View the Agenda for OCRA’s Ovarian Cancer National Conference

View the Agenda for OCRA’s Ovarian Cancer National Conference

Don’t miss a weekend packed with information and inspiration, July 12-14 in Seattle, Washington! Friday, July 12thWelcome to Seattle! Arrive in early afternoon and catch an optional Seattle Bus Tour, or settle in and get comfortable before you head out to meet new friends at our Newcomers, Community Partners, and Men’s receptions. Catch a special Our … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.